Evidence map›Paper›PMID 42113901›Full record

ArticleAmerican journal of respiratory cell and molecular biology2026

Refueling T cell memory in cystic fibrosis.

Michael Shlossman, Daniel P Cook

Abstract readEditorialComment
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Michael ShlossmanDivision of Pulmonary, Critical Care, and Occupational Medicine, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, United States.
Daniel P CookDivision of Pulmonary, Critical Care, and Occupational Medicine, Department of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, IA, United States.ORCID 0000-0002-1152-4454

Funding

Inhibiting CD4+ Th2 development and function by CFTR activity.K08AI181763 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Daniel Paul Cook · 2024 to 2026
$553k
CFF COOK20L0CFF COOK24A0-KBCFF COOK25R3CFF STOLTZ24R0NIAID NIH HHS K08AI181763
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42113901
PMCPMC13624501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.